NNVC vs OKTA · $22.2M cap vs P/E 84, rev $1.57B
NanoViricides Inc (NNVC) versus Okta Inc (OKTA) — a side-by-side from cached financials, not a winner call.
NanoViricides Inc (NNVC) is a biotechnology company listed on US.
Okta Inc (OKTA) is a software - infrastructure company listed on NASDAQ.
Latest reported NNVC revenue for 2026-03-31 was $0. Net income was -$6.0M. NNVC currently screens at market cap $22.2M.
Latest reported OKTA revenue for 2026-07-31 was $1.57B. Net income was $190.0M. OKTA currently screens at market cap $20.06B and trailing P/E 83.6.
NNVC currently screens at market cap $22.2M. OKTA currently screens at market cap $20.06B and trailing P/E 83.6.
Not investment advice. Open the NNVC and OKTA stock pages for the full models.
Not investment advice.